Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: A new look

British Journal of Clinical Pharmacology

Volumn 66, Issue 1, 2008, Pages 76-81

  Opatrny, Lucie ^a   Delaney, J A Chris ^a,b   Suissa, Samy ^a,b,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Alcohol; Confounding; Gastro intesinal haemorrhage; Reuptake inhibitors; Selective serotonin; Warfarin

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CELECOXIB; CLOPIDOGREL; CORTICOSTEROID; DEXKETOPROFEN; DICLOFENAC; DIFLUNISAL; DIURETIC AGENT; FENBUFEN; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; LITHIUM; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADRENERGIC UPTAKE INHIBITORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DRUG INTERACTIONS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; TICLOPIDINE; WARFARIN;

EID: 44949109396     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03154.x     Document Type: Article

References (25)

1. Rockall T, Logan R, Devlin H, Northfield T. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995 311 : 222 6.
2. Dalton S, Johansen C, Mellemkjoer L, Norgard B, Sorensen H, Olsen J. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. Arch Intern Med 2003 163 : 59 64.
3. de Abajo F, Garcia-Rodriguez L, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding; population based case-control study. BMJ 1999 319 : 1106 9.
4. Meijer W, Heerdink E, Nolen W, Herings R, Leufkens H, Egberts A. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004 164 : 2367 70.
5. van Walraven C, Mamdani M, Wells P, Williams J. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001 323 : 655 8.
6. Po A. Antidepressants and upper gastrointestinal bleeding. BMJ 1999 319 : 1081 2.
7. Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Clin Pharmacol 2006 62 : 509 11.
8. Holbrook A, Pereira J, Labiris R, McDonald M, Douketis J, Crowther M, Wells P. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005 165 : 1095 106.
9. Suissa S, Bourgault C, Barkun A, Sheehy O, Ernst P. Antihypertensive drugs and the risk of gastrointestinal bleeding. Am J Med 1998 105 : 230 5.
10. Jick S. The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam. Pharmacotherapy 2000 20 : 741 4.
11. Jick S, Kaye J, Vasilakis-Scaramozza C, Garcia Rodriguez L, Ruigomez A, Meier C. Validity of the general research practice database. Pharmacotherapy 2003 23 : 686 9.
12. Walley T, Mantgani A. The UK general practice research database. Lancet 1997 350 : 1097 9.
13. Garcia Rodriguez L, Perez Gutthann S. Use of the UK general research database for pharmacoepidemiology. Br J Clin Pharmacol 1998 45 : 425.
14. Lawrenson R, Williams T, Farmer R. Clinical information for research: the use of general practice databases. J Public Health Med 2006 23 : 299 304.
15. Wood L, Martinez C. The general research practice database: role in pharmacovigilence. Drug Saf 2004 27 : 871 81.
16. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford : Oxford University Press, 1993 161 2.
17. Suissa S. Novel approaches to pharmacoepidemiology study design and statistical analysis. In : Strom BL, ed. Pharmacoepidemiology. Chichester : John Wiley & Sons 2000 785 805.
18. Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 1995 56 : 574 9.
19. Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp L, Crowell M, Keshavarzian A, Jones M. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006 23 : 937 44.
20. Kurdyak P, Juurlink D, Kopp A, Hermann N, Mamdani M. Antidepressants, warfarin and the risk of hemorrhage. J Clin Psychopharmacol 2005 25 : 561 4.
21. Thomsen R, Riis A, Christensen S, Norgaard M, Sorensen HT. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population basedcohort study. Diabetes Care 2006 29 : 805 10.
22. Nakaya N, Saito-Nakaya K, Akizuki N, Yoshikawa E, Kobayakawa M, Fujimori M, Nagai K, Nishiwaki Y, Fukudo S, Tsubono Y, Uchitomi Y. Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci 2006 97 : 199 205.
23. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993 270 : 1819 25.
24. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007 62 : 31 8.
25. Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 2007 177 : 347 51.